Starling Oncology, Inc. (STLN): Weighted Average Diluted Shares
92.39M
Year ended 2025-12-31
+4.7%
3-year compound annual growth
+9.3%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 92.39M | +23.1% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | 75.04M | +1.8% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | 73.75M | -8.5% | 2025-03-26, From 2023-01-01 |
| 2022-12-31 | 80.61M | +21.7% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | 66.23M | +12.0% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | 59.12M | n/a | 2022-03-11, From 2020-01-01 |